Navigation Links
Cancer Vaccines: From First-in-Class to Best-in-Class?
Date:4/9/2013

cules 389
9.1.1 Background 389
9.1.2 Target Strategies of Small Molecule Drugs 390
9.2 Peptide & Protein Drugs 392
9.2.1 Background 392
9.2.2 Target Strategies of Peptide and Protein Drugs 393
9.3 Antibodies 400
9.3.1 Background 400
9.3.2 Target Strategies of Antibody Drugs 400
9.4 Nucleic Acid Therapies 403
9.4.1 Background 403
9.4.2 Target Strategies of Nucleic Acid Drugs 404
9.5 Cell & Gene Therapy 407
9.5.1 Background 407
9.5.2 Target Strategies of Cell and Gene Therapy Drugs 408
10 The Competition Through Close Mechanistic Approximation of Cancer Vaccine Drugs 414
11 Selecting Indications for Cancer Vaccine Drugs 417
11.1 Acute Lymphocytic Leukemia 420
11.2 Acute Myelogenous Leukemia 421
11.3 Acute Promyelocytic Leukemia 423
11.4 Anal Dysplasia 424
11.5 B-cell Lymphoma 425
11.6 Biliary Cancer 426
11.7 Bladder Cancer 427
11.8 Bone Cancer 428
11.9 Brain Cancer 429
11.10 Breast Cancer 431
11.11 Cancer (general) 434
11.12 Cervical Cancer 435
11.13 Cervical Dysplasia 438
11.14 Chronic Myelogenous Leukemia 440
11.15 Colorectal Adenoma 441
11.16 Colorectal Cancer 442
11.17 Endometrial Cancer 445
11.18 Fallopian Tube Cancer 446
11.19 Gastrointestinal Cancer (general) 447
11.20 Gastrointestinal Stomach Cancer 448
11.21 Glioma 449
11.22 Head and Neck Cancer 450
11.23 Hematological Cancer (general) 452
11.24 Leukemia (general) 453
11.25 Liver Cancer 454
11.26 Lung Cancer (general) 455
11.27 Lymphoma (general) 458
11.28 Melanoma 459
11.29 Merkel cell carcinoma 462
11.30 Mesothelioma 463
11.31 Myelodysplastic Syndrome 464
11.32 Myeloma 465
11.33 non-Hodgkin's Lymphoma 466
11.34 Non-Small Cell Lung Cancer 467
11.35 Oesophageal Cancer 469
11.36 Osteo Sarcoma 470
11.37 Ovarian Cancer 471
11.38 Pancreatic Cancer 473
11.39 P
'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related medicine technology :

1. NewGen Therapeutics Presents Data on NT-113, A Novel Pan-ErbB Inhibitor, at American Association of Cancer Research
2. Exosome Presents Late-Breaking Study Demonstrating Ability to Profile RNA from Archived Clinical Trial Blood Samples at 2013 American Association of Cancer Research Annual Meeting
3. Take the Skyhook Challenge and Help Beat Blood Cancer
4. Merrimack Pharmaceuticals Preclinical Research Shows MM-121 Restores Sensitivity to Anti-Estrogen Therapy and Delays Onset of Treatment Resistance in ER-Positive Breast Cancer Model
5. Positive Preclinical Data for NKTR-214, an Investigational Cancer Immunotherapy Targeting the IL-2 Receptor Complex, Presented at AACR Annual Meeting 2013
6. Penn Medicines New Center For Personalized Diagnostics Unlocks Cancers Secrets
7. Cerulean Pharma to Present Data on CRLX101s HIF-1a Inhibition at the American Association for Cancer Research Annual Meeting
8. Merrimack Pharmaceuticals Announces Top-Line Results From A Single Arm Phase 2 Advanced Lung Cancer Study In Patients With Resistance To An Anti-EGFR Tyrosine Kinase Inhibitor
9. NewLink Genetics Presents Preclinical Data on NLG919, a New Drug Candidate from a Novel Class of IDO Pathway Inhibitors for the Treatment of Cancer
10. National Cancer Organizations Issue Joint Statement On Devastating Impact Of Sequestration
11. DelMar Pharmaceuticals to Present Clinical Data from VAL-083 Brain Cancer Trial at the American Association of Cancer Research Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... , July 1, 2015  MEI Pharma, Inc. (Nasdaq: ... development of novel therapies for cancer, announced today that ... will present at the inaugural Cantor Fitzgerald Healthcare Conference on ... Le Parker Meridien in New York ... accessed at www.meipharma.com . A replay will be available ...
(Date:7/1/2015)... , July 1, 2015  LabStyle Innovations Corp. ... today announced the appointment of Todd Durniak as Senior ... Durniak brings to LabStyle over 20 years of ... as the Vice President and General Manager of ... delivering insulin supplies through durable medical equipment (DME) ...
(Date:7/1/2015)... 2015 Lupin , ... Total Number of MPP Sub-licensees to Fourteen Companies   ... announced the rapid expansion of its network of generic manufacturers ... to develop MPP-licensed antiretrovirals (ARVs). New companies Lupin and Strides ... new HIV medicine the MPP licensed from ViiV Healthcare two ...
Breaking Medicine Technology:MEI Pharma to Present at Cantor Fitzgerald Healthcare Conference 2LabStyle Innovations Appoints Senior VP & General Manager in U.S. for the Dario Diabetes Management Solution 2LabStyle Innovations Appoints Senior VP & General Manager in U.S. for the Dario Diabetes Management Solution 3LabStyle Innovations Appoints Senior VP & General Manager in U.S. for the Dario Diabetes Management Solution 4The Medicines Patent Pool Increases its Generic Manufacturing Network to Ramp-Up Production of Low Cost Antiretrovirals (ARVs) 2The Medicines Patent Pool Increases its Generic Manufacturing Network to Ramp-Up Production of Low Cost Antiretrovirals (ARVs) 3
... Oct. 28 Adeona Pharmaceuticals, Inc., (AMEX: AEN ... Shareholders Meeting on Tuesday, November 2, from 9 a.m. to ... Ann Arbor, MI, 48108. During the Annual ... M.B.A., will give an update on the Company,s activities and ...
... DIEGO, Oct. 27 Gen-Probe Incorporated (Nasdaq: GPRO ... Oppenheimer 21st Annual Healthcare Conference in New York on November ... Lazard Capital Markets 7th Annual Healthcare Conference in New York ... presentations are scheduled to be webcast live and may be ...
Cached Medicine Technology:Gen-Probe to Webcast Two Upcoming Investor Presentations 2
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... ... solution provider of IBM software products, announced today that it has received trademark ... the integration, display and detailed analysis of data from multiple sources providing an ...
(Date:7/1/2015)... ... 01, 2015 , ... A Priority Setting Partnership put in ... list they hope will guide future mesothelioma research. Surviving Mesothelioma has just posted ... , More than 450 mesothelioma patients, caregivers, and healthcare professionals answer the ...
(Date:7/1/2015)... ... 01, 2015 , ... Author Francesca Camp wasn’t always a steadfast supporter of plastic ... did her support of the practice; a terrible car accident years ago left her injured ... “Do I Need It ? (And What if I Do?): Answers to All Your Questions ...
(Date:7/1/2015)... ... July 01, 2015 , ... After conducting a ... Smith, Tri-City Medical Center in Oceanside, Calif., has hired Cheryle Bernard-Shaw ... leading organization-wide compliance adaptation efforts and growing a focus on risk management, Bernard-Shaw ...
(Date:7/1/2015)... ... July 01, 2015 , ... Incentivizing the use of generic drugs has been ... much as 80% or 90% off the prices for the brand-name products. But now ... mitigate the financial impact of these high-cost generic drugs. The July issue of Atlantic ...
Breaking Medicine News(10 mins):Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 3Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 4Health News:New Report Identifies Top 10 Mesothelioma Research Priorities, According to Surviving Mesothelioma 2Health News:Francesca Camp’s New Book Unmasks Plastic Surgery Advice 2Health News:Tri-City Medical Center Hires New Chief Compliance Officer 2Health News:Tri-City Medical Center Hires New Chief Compliance Officer 3Health News:Blues Execs Share Strategies for Managing Generic Drug Inflation in AIS Newsletter 2Health News:Blues Execs Share Strategies for Managing Generic Drug Inflation in AIS Newsletter 3
... [24-hour telephone access to language interpreters] to firms ... ... Washington, D.C. (Vocus) July 25, 2008 ... Inc.)], a leading provider of interpretation, translation, and language instruction ...
... be used to facilitate the planning and designing of new ... ... Hauppauge, NY (PRWEB) July 25, 2008 -- IVCi, LLC ( ... including high definition video conferencing, telepresence, audio visual integration, and ...
... July 24 Speaker Nancy Pelosi,released the following statement ... J. Hyde Global Leadership Against HIV/Aids, Tuberculosis, and,Malaria Reauthorization ... last,week, passed the House this evening by a vote ... for his signature into law., "Today the House ...
... by GPs and primary care docs, survey finds , , ... 2005, the number of prescriptions filled for antidepressant drugs ... a report released Thursday by the U.S. government. , ... Quality, of antidepressant prescriptions (not including refills) written after ...
... AMICAS, Inc. (Nasdaq: AMCS ),a leader in radiology ... report the company,s financial results,for the second quarter ending June ... (Logo: http://www.newscom.com/cgi-bin/prnh/20060202/AMICASLOGO ), ... August 5, 2008 -- Call begins promptly ...
... macular degeneration (AMD) is the commonest cause of ... in the regulation of the immune system influence ... University Clinic in Bonn, working in co-operation with ... now, for the first time, demonstrated that in ...
Cached Medicine News:Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3Health News:Mt. Sinai's Children's Trauma Institute Treatment and Service Adaptation Center Receives Video Conferencing Donation From IVCi 2Health News:Pelosi Statement on House Passage of Global AIDS Legislation 2Health News:AMICAS Schedules Second Quarter Earnings Call 2Health News:Hyperactive immune resistance brings blindness in old age 2
... warfarin for use by healthcare professionals and ... easy-to-read back-lit display and an operator rechargeable ... the ability to auto-send results to a ... LIS or EMR database through a clinical ...
... easiest test to use on the market. Rapid ... hands-on time. Critical care instructions can be provided ... pediatrician's office. Valuable information can be obtained prior ... the focus can be on the results and ...
The INRatio meter is a diagnostic Point Of Care system that provides Prothrombin Time (PT) and International Normalized Ratio (INR) results using one drop of fresh capillary whole blood from a finger...
... for the rapid detection of 5 commonly abused drugs ... test cup and test card. After the urine is ... sealed with a lid. Results are read 3-8 minutes ... card to read the result. The urine sample cup ...
Medicine Products: